Docetaxel Accord 20 mg/1 ml concentrate for solution for infusion, Trodelvy 200 mg powder for concentrate for solution for infusion
GS-US-577-6153
Phase 3 small_molecule active
Quick answer
Docetaxel Accord 20 mg/1 ml concentrate for solution for infusion, Trodelvy 200 mg powder for concentrate for solution for infusion for Non-small cell lung cancer is a Phase 3 program (small_molecule) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences International Limited
- Indication
- Non-small cell lung cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active